Document is current
Any future updates will be listed below
-
Authors
Bi, Xinyuan
Ma, Bin
Liu, Wei
Gao, Wei-Qiang
Ye, Jian
Rao, Hanyu https://orcid.org/0000-0003-1286-8707
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82203255)
National Natural Science Foundation of China (82272054)
National Natural Science Foundation of China (W2431055)
Major Projects of Special Development Fund in Shanghai Zhangjiang National Independent Innovation Demonstration Zone (ZJ2021-ZD-007)
Shanghai Key Laboratory of Gynecologic Oncology, Shanghai Jiao Tong University (YG2024LC09)
Shanghai Jiao Tong University Trans-med Awards Research (STAR) Project (WF540162608)
Science and Technology Commission of Shanghai Municipality (24DIPA00300)
Sichuan Province Science and Technology Support Program (2024ZYD0112)
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 10 December 2024
First Online: 18 December 2024
Declarations
:
: This study was conducted at the School of Biomedical Engineering and Clinical Stem Cell Research Center, Shanghai Jiao Tong University. Approval was granted for a project titled “Cancer Immunotherapy Using Umbilical Cord Mesenchymal Stem Cells” in 2021 by the Renji Hospital Ethics Committee (No. KY2021-027). All participants provided informed consent.
: Not applicable.
: The authors declare no competing interests.
